Literature DB >> 7229372

The role of complement in the localization of pneumococci in the splanchnic reticuloendothelial system during experimental bacteremia.

E J Brown, S W Hosea, M M Frank.   

Abstract

Pneumococci activate the alternative complement (C) pathway in the absence of demonstrable antibody in normal guinea pig serum. They also activate the classical C pathway in the presence of type-specific antibody and perhaps through other mechanisms as well. A quantitative examination was undertaken of the roles of these 2 pathways of C activation in the splanchnic sequestration of 125I-labeled pneumococci, using a-guinea pig model of pneumococcal bacteremia. Normal unimmunized guinea pigs (NIH-GP) localized more than 3 times as many pneumococci to the liver as the spleen during a period when exponential bloodstream clearance was occurring. C4-deficient guinea pigs (C4D-GP) and cobra venom factor-treated guinea pigs (CVF-GP) showed progressively fewer pneumococci cleared by the liver with concomitant increases in the extent of splenic uptake, demonstrating the important role of C in the clearance of bacteria in the unimmunized animal. Immunization of guinea pigs brought about an increase in pneumococcal sequestration by the liver in NIH and C4D-GP but did not affect the localization pattern of CVF-GP. A comparison of reticuloendothelial system (RES) localization patterns with the rate of removal of bacteria from the bloodstream showed a highly significant correlation between increases in splenic sequestration and persistence of bacteremia. Thus, opsonization by C is an important determinant of the RES clearance of pneumococci. Unlike RBC clearance, where C plus IgM leads to hepatic localization, and C plus IgG tends to produce splenic localization, C in the presence or absence of type-specific antibody tends to cause hepatic localization of pneumococci. When C-mediated opsonic activity is less than optimal, the slower clearance of bacteremia that results is accompanied by an increased dependence on splenic sequestration of pneumococci.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7229372

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.

Authors:  Jeremy S Brown; Tracy Hussell; Sarah M Gilliland; David W Holden; James C Paton; Michael R Ehrenstein; Mark J Walport; Marina Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

2.  Role of splenectomy in the pathogenesis of Haemophilus influenzae type f meningitis.

Authors:  F P Meier; F A Waldvogel; A Zwahlen
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

Review 3.  Lectinophagocytosis: a molecular mechanism of recognition between cell surface sugars and lectins in the phagocytosis of bacteria.

Authors:  I Ofek; N Sharon
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

Review 4.  The role of complement in host resistance to bacteria.

Authors:  E J Brown; K A Joiner; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1983

5.  A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.

Authors:  E J Brown; S W Hosea; C H Hammer; C G Burch; M M Frank
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

6.  Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.

Authors:  Martina M Ochs; William Bartlett; David E Briles; Bryony Hicks; Audra Jurkuvenas; Peggy Lau; Bing Ren; Amanda Millar
Journal:  Microb Pathog       Date:  2007-10-11       Impact factor: 3.738

7.  Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

Authors:  Jose Yuste; Ashwin Sen; Lennart Truedsson; Göran Jönsson; Liang-Seah Tay; Catherine Hyams; Helen E Baxendale; Fiona Goldblatt; Marina Botto; Jeremy S Brown
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

8.  Enhanced susceptibility of mice with streptozotocin-induced diabetes to type II group B streptococcal infection.

Authors:  M S Edwards; P A Fuselier
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Effect of splenic sequestration of erythrocytes on splenic clearance function and susceptibility to septic peritonitis.

Authors:  G J Grover; D J Loegering
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

10.  Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae.

Authors:  C J Liang-Takasaki; H Saxén; P H Mäkelä; L Leive
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.